|
1.
|
原著(症例報告除く)
|
Immediate and Longitudinal Outcomes of a National Hands-On Basic Research Course in Rhinology. 2026/07
|
|
2.
|
その他
|
α4 Nicotinic Acetylcholine Receptor Signaling Exacerbates Type 2 Airway Inflammation. 2026/07
|
|
3.
|
原著(症例報告除く)
|
Macrophage Migratory Inhibitory Factor May Contribute to the Production of Nitric Oxide in Obstructive Sleep Apnea. 2026/04
|
|
4.
|
その他
|
The Clinical Value of Measuring Nasal Nitric Oxide in Addition to Exhaled Nitric Oxide in Asthma Associated With Eosinophilic Chronic Rhinosinusitis. 2026/04
|
|
5.
|
原著(症例報告除く)
|
Macrophage Migratory Inhibitory Factor May Contribute to the Production of Nitric Oxide in Obstructive Sleep Apnea 2025/08
|
|
6.
|
原著(症例報告除く)
|
CCL4 Affects Eosinophil Survival via the Shedding of the MUC1 N-Terminal Domain in Airway Inflammation 2024/12
|
|
7.
|
原著(症例報告除く)
|
Mouse eosinophil-associated ribonuclease-2 exacerbates the allergic response 2024/08
|
|
8.
|
原著(症例報告除く)
|
CD69 Signaling in Eosinophils Induces IL-10 Production and Apoptosis via the Erk1/2 and JNK Pathways, Respectively 2024/03
|
|
9.
|
原著(症例報告除く)
|
The Neutralization of the Eosinophil Peroxidase Antibody Accelerates Eosinophilic Mucin Decomposition 2023/11
|
|
10.
|
症例報告
|
Omalizumab is effective for a patient with pollen-food allergy syndrome who experienced intractable lip edema 2023/10
|
|
11.
|
症例報告
|
歯性感染症が契機と考えられたAggregatibacter aphrophilusによる脳膿瘍の一症例 2023/07
|
|
12.
|
原著(症例報告除く)
|
Inoculation of lymphocytes from young mice prevents progression of age-related hearing loss in a senescence-associated mouse model 2023/06
|
|
13.
|
原著(症例報告除く)
|
レンバチニブ併用放射線療法による新たな甲状腺癌治療の可能性 2022/12
|
|
14.
|
症例報告
|
Clinicopathological investigation of secretory carcinoma cases including a successful treatment outcome using entrectinib for high-grade transformation: a case report 2022/01
|
|
15.
|
原著(症例報告除く)
|
Long-term sublingual immunotherapy provides better effects for patients with Japanese cedar pollinosis 2021/08
|
|
16.
|
原著(症例報告除く)
|
Omalizumab restores response to corticosteroids in patients with eosinophilic chronic rhinosinusitis and severe asthma 2021/06
|
|
17.
|
原著(症例報告除く)
|
Corrigendum to "The multiple functions and subpopulations of eosinophils in tissues under steady-state and pathological conditions" [Allergol Int 70 (2021) 9-18] 2021/04
|
|
18.
|
原著(症例報告除く)
|
Odontogenic maxillary sinusitis: therapeutic management of cases with oroantral fistulae 2021/03
|
|
19.
|
原著(症例報告除く)
|
Combination therapy with lenvatinib and radiation significantly inhibits thyroid cancer growth by uptake of tyrosine kinase inhibitor 2021/01
|
|
20.
|
総説
|
The multiple functions and subpopulations of eosinophils in tissues under steady-state and pathological conditions 2021/01
|
|
21.
|
原著(症例報告除く)
|
吸入ステロイド経鼻呼出療法が鼻腔内常在細菌叢に及ぼす影響についての検討 2021/01
|
|
22.
|
原著(症例報告除く)
|
好酸球性副鼻腔炎鼻茸組織中好酸球おけるCD69分子の発現と機能 2020/06
|
|
23.
|
原著(症例報告除く)
|
甲状腺癌細胞株に対する放射線療法とレンバチニブの相乗効果 2020/06
|
|
24.
|
原著(症例報告除く)
|
慢性炎症の原因除去と免疫若返りによる老人性難聴予防 2020/06
|
|
25.
|
原著(症例報告除く)
|
Increased CD69 expression on activated eosinophils in eosinophilic chronic rhinosinusitis correlates with clinical findings. 2020/04
|
|
26.
|
その他
|
好酸球性副鼻腔炎における包括的気道炎症制御 Airway Medicineについて(解説) 2020/03
|
|
27.
|
原著(症例報告除く)
|
Reduced local response to corticosteroids in eosinophilic chronic rhinosinusitis with asthma 2020/02
|
|
28.
|
原著(症例報告除く)
|
Multiple biological aspects of eosinophils in host defense, eosinophil-associated diseases, immunoregulation, and homeostasis: is their role beneficial, detrimental, regulator, or bystander? 2020
|
|
29.
|
症例報告
|
Eosinophilic cholecystitis occurred in a patient with refractory eosinophilic airway inflammation: a case report. 2019/08
|
|
30.
|
原著(症例報告除く)
|
A novel approach for investigating upper airway hyperresponsiveness using micro-CT in eosinophilic upper airway inflammation such as allergic rhinitis model. 2019/06
|
|
31.
|
原著(症例報告除く)
|
Critical role of CCL4 in eosinophil recruitment into the airway. 2019/06
|
|
32.
|
原著(症例報告除く)
|
老人性難聴モデルマウスにおけるCD4+Tリンパ球分画移入による難聴予防 2019/05
|
|
33.
|
原著(症例報告除く)
|
Prevention of hearing loss by alteration of the systemic immune system 2019/03
|
|
34.
|
原著(症例報告除く)
|
Eosinophilic upper airway inflammation in a murine model using an adoptive transfer system induces hyposmia and epithelial layer injury with convex lesions 2019/02
|
|
35.
|
原著(症例報告除く)
|
Regulation of interaction between the upper and lower airways in united airway disease. 2019/02
|
|
36.
|
原著(症例報告除く)
|
A comparison of short-term outcomes of neck dissection for head and neck cancers using thunderbeatTM, LigaSureTM or treatment without an energy-based device: a case controlled study. 2018/10
|
|
37.
|
原著(症例報告除く)
|
Indications for partial parotidectomy using retrograde dissection of the marginal mandibular branch of the facial nerve for benign tumours of the parotid gland. 2018/10
|
|
38.
|
原著(症例報告除く)
|
HFA-BDP metered-dose inhaler exhaled through the nose improves eosinophilic chronic rhinosinusitis with bronchial asthma: a blinded, placebo-controlled study 2018/09
|
|
39.
|
原著(症例報告除く)
|
Cells expressing prominin-1 in neonatal murine inferior colliculus differentiate into neurons and glia. 2018/06
|
|
40.
|
原著(症例報告除く)
|
好酸球性副鼻腔炎由来組織好酸球は活性化し、炎症性サイトカインを有意に発現する 2018/05
|
|
41.
|
その他
|
難治性好酸球性気道炎症の病態をステロイド感受性から探る 2018/05
|
|
42.
|
その他
|
Residual recurrent nerve paralysis after esophagectomy is associated with preoperative lower serum albumin 2017/08
|
|
43.
|
原著(症例報告除く)
|
OSAS患者における病勢マーカーとしての鼻腔NO 2017/06
|
|
44.
|
原著(症例報告除く)
|
Impaired dual-specificity protein phosphatase DUSP4 reduces corticosteroid sensitivity 2017/05
|
|
45.
|
原著(症例報告除く)
|
IL-22/IL-22R1 signaling regulates the pathophysiology of chronic rhinosinusitis with nasal polyps via alteration of MUC1 expression 2017/01
|
|
46.
|
その他
|
鼻科基礎研究ハンズオンセミナーの取り組み(第2報) 2016/07
|
|
47.
|
その他
|
【アレルギー性鼻炎-新たな研究と治療の展開】 アレルギー性鼻炎研究の新たな展開 好酸球 2016/06
|
|
48.
|
その他
|
休止期でなく活性化型好酸球が好酸球由来IFN-γを介して気道炎症を促進する(Activated but not resting eosinophils promote airway inflammation through eosinophil-derived IFN-γ) 2016/04
|
|
49.
|
原著(症例報告除く)
|
Residual exhaled nitric oxide elevation in asthmatics is associated with eosinophilic chronic rhinosinusitis 2015/12
|
|
50.
|
その他
|
Th2-activated eosinophils release Th1 cytokines that modulate allergic inflammation 2015/09
|
|
51.
|
その他
|
(報告)鼻科基礎研究ハンズオンセミナーの取り組みと今後の課題 2015/07
|
|
52.
|
その他
|
Bystander immunotherapy as a strategy to control allergen-driven airway inflammation 2015/07
|
|
53.
|
その他
|
好酸球浸潤と耳鼻科疾患(特集 好酸球浸潤を伴う疾患) 2015/07
|
|
54.
|
その他
|
気道炎症におけるCX3CR1の機能的役割 2015/06
|
|
55.
|
その他
|
気道炎症局所の好酸球は多様なフェノタイプを有し炎症を制御する 2015/05
|
|
56.
|
その他
|
Nasal-bronchial reflex による上気道と下気道の interaction と当教室における気道外来の取り組み 2015/04
|
|
57.
|
その他
|
New classification focusing on implant designs useful for setting therapeutic strategy for periprosthetic femoral fractures 2015/01
|
|
58.
|
原著(症例報告除く)
|
CX3CL1 (fractalkine) and its receptor CX3CR1 regulate atopic dermatitis by controlling effector T cell retention in inflamed skin 2014/06
|
|
59.
|
その他
|
好酸球 好酸球性副鼻腔炎における術前後上下気道評価について 2013/09
|
|
60.
|
その他
|
免疫アレルギー学の最前線 好酸球増多を伴う気道炎症とIFN-γによるTh1/Th2制御 2012/10
|
|
61.
|
総説
|
免疫アレルギー学の最前線 好酸球増多を伴う気道炎症とIFN-γによるTh1/Th2制御 2012/10
|
|
62.
|
その他
|
Eosinophils induce lung inflammation in the absence of lymphocytes. 2012/04
|
|
63.
|
原著(症例報告除く)
|
Langerin+ dendritic cells are responsible for LPS-induced reactivation of allergen-specific Th2 responses in post-asthmatic mice. 2011/03
|
|
64.
|
原著(症例報告除く)
|
Allergic Lung Inflammation is Mediated by Soluble TNF and Attenuated by Dominant-negative TNF Biologics. 2011/02
|
|
65.
|
原著(症例報告除く)
|
The oral administration of bacterial extracts prevents asthma via the recruitment of regulatory T cells to the airways 2011/01
|
|
66.
|
原著(症例報告除く)
|
CX3CR1 is required for airway inflammation by promoting T helper cell survival and maintenance in inflamed lung 2010/10
|
|
67.
|
原著(症例報告除く)
|
Breast milk immune complexes are potent inducers of oral tolerance in neonates and prevent asthma development. 2010/09
|
|
68.
|
原著(症例報告除く)
|
Regulation of Th2 Responses and Allergic Inflammation through Bystander Activation of CD8+ T Lymphocytes in Early Life. 2010/07
|
|
69.
|
原著(症例報告除く)
|
Eosinophil-derived IFN-gamma induces airway hyperresponsiveness and lung inflammation in the absence of lymphocytes. 2009/06
|
|
70.
|
原著(症例報告除く)
|
Fc(epsilon)RI and FcgammaRIII/CD16 differentially regulate atopic dermatitis in mice. 2009/05
|
|
71.
|
原著(症例報告除く)
|
PPAR-α regulates skin inflammation and humoral response in atopic dermatitis. 2008/02
|
|
72.
|
原著(症例報告除く)
|
Breast milk-mediated transfer of an airborne antigen induces immune tolerance and protection from allergic airway disease in mice 2008/01
|
|
73.
|
原著(症例報告除く)
|
Possible novel receptor for PGD2 on human bronchial epithelial cells. 2007/05
|
|
74.
|
原著(症例報告除く)
|
Prostaglandin D2 induces IL-8 and GM-CSF by bronchial epithelial cells in a CRTH2-independent pathway. 2006/08
|
|
75.
|
原著(症例報告除く)
|
Physiological levels of 15-deoxy-Δ12, 14-prostaglandin J2 prime eotaxin-induced chemotaxis on human eosinophils 2005/11
|
|
76.
|
原著(症例報告除く)
|
市中病院での平衡機能検査に対する検査科の役割 2005/10
|
|
77.
|
原著(症例報告除く)
|
The synthetic PPAR gamma agonist troglitazone inhibits IL-5-induced CD69 upregulation and eosinophil-derived neurotoxin release from eosinophils. 2005/07
|
|
78.
|
その他
|
高感度CRP とアレルギー性炎症疾患． 2005
|
|
79.
|
その他
|
末梢血好酸球におけるProstaglandin D2の作用－CRTH2およびDP 受容体について－． 2005
|
|
80.
|
原著(症例報告除く)
|
院内感染対策による抗菌薬使用削減効果 2004/12
|
|
81.
|
原著(症例報告除く)
|
Red Blood Cells Regulate Eosinophil Chemotaxis by Scavenging RANTES Secreted from Endothelial Cells 2004/10
|
|
82.
|
原著(症例報告除く)
|
Activation of Eosinophils by Rice-Husk Dust Exposure: A Possible Mechanism for the Aggravation of Asthma during Rice Harves 2004/09
|
|
83.
|
原著(症例報告除く)
|
Activation of Epidermal Growth Factor Receptor via CCR3 in Bronchial Epithelial Cells. 2004/07
|
|
84.
|
原著(症例報告除く)
|
Peroxisome proliferator-activated receptor gamma regulates eosinophil functions: a new therapeutic target for allergic airway inflammation. 2004/06
|
|
85.
|
原著(症例報告除く)
|
Prostaglandin D2 and IL-5 reduce CRTH2 surface expression on human eosinophils. 2004/02
|
|
86.
|
原著(症例報告除く)
|
The Role of Adhesion Molecules in Eosinophil Activation: -The Comparative Study on The Effect of Adhesion Molecules on Eosinophil Survival -. 2004/02
|
|
87.
|
総説
|
アレルギーとケモカイン：好酸球関連ケモカインを中心に 2004
|
|
88.
|
その他
|
気道上皮細胞eotaxin刺激によるIL-8産生・増殖とシグナル伝達の役割 JNKリン酸化とERK1/2,p38の機能的役割の違い 2004
|
|
89.
|
その他
|
好酸球に及ぼすPPARγアゴニストの機能について 2004
|
|
90.
|
原著(症例報告除く)
|
Effect of Ketotifen on the production of reactive oxygen species from human eosinophils primed by eotaxin. 2003/11
|
|
91.
|
原著(症例報告除く)
|
Expression of PPARgamma in eosinophils and its functional role in survival and chemotaxis. 2003/04
|
|
92.
|
総説
|
気道過敏における好酸球の役割 2003
|
|
93.
|
総説
|
気道上皮細胞と好酸球 2003
|
|
94.
|
総説
|
気道上皮細胞のeotaxin刺激によるサイトカイン産生とMAPキナーゼについて 2003
|
|
95.
|
総説
|
遺伝性呼吸器疾患における遺伝子診断 2002
|
|
96.
|
症例報告
|
鼻閉感を主訴とした化学物質過敏症の一症例 2000/04
|
|
97.
|
その他
|
炎症性メディエーターによる鼻粘膜血管内皮細胞内Ca2+濃度変化と受容体拮抗薬の作用 2000
|
|
98.
|
総説
|
肺のアレルギー・炎症 - 気管支喘息を中心に 2000
|
|
99.
|
その他
|
炎症性メディエーターに対する培養ヒト鼻粘膜血管内皮細胞の細胞内Ca2+動態 1999
|
|
100.
|
原著(症例報告除く)
|
高齢者頭頸部癌患者における手術治療の検討 1998/03
|
|
101.
|
その他
|
培養ヒト鼻粘膜血管内皮細胞の細胞内Ca2+動態に対するロイコトリエンの作用 1998
|
|
5件表示
|
|
全件表示(101件)
|
